{ "api_version": "1", "request": { "url": "https://clinicaltrialsfind.com/api/v1/search.json?intervention=Control+II&page=16", "query": { "intervention": "Control II", "page": 16 }, "page_size": 10 }, "pagination": { "page": 16, "page_size": 10, "total_count": 2665, "total_pages": 267, "next_page_url": "https://clinicaltrialsfind.com/api/v1/search.json?intervention=Control+II&page=17&page_size=10", "previous_page_url": "https://clinicaltrialsfind.com/api/v1/search.json?intervention=Control+II&page=15&page_size=10" }, "source": "remote", "last_synced_at": "2026-10-22T23:53:21.453Z", "attribution": "Data derived from public ClinicalTrials.gov records. The official record at https://clinicaltrials.gov/ remains the source of truth for current availability, contacts, and full study details.", "notes": [ "This endpoint exposes only public summary fields — no participant contact emails, phone numbers, or scraped investigator contact details.", "For contact information and full protocol detail, follow each trial's `official_url` to the ClinicalTrials.gov record.", "This API is a navigational aid. It does not provide medical advice, eligibility determinations, or compensation guarantees." ], "trials": [ { "nct_id": "NCT05591079", "title": "A Study to Assess the Safety, Tolerability, Pharmacokinetics and Efficacy of CS0159 in Subjects With NASH", "overall_status": "COMPLETED", "study_type": "INTERVENTIONAL", "phases": [ "PHASE2" ], "conditions": [ "Nonalcoholic Steatohepatitis (NASH)" ], "interventions": [ { "name": "CS0159 (Linafexor)", "type": "DRUG" } ], "intervention_types": [ "DRUG" ], "sponsor": "Cascade Pharmaceuticals, Inc", "sponsor_class": "OTHER", "healthy_volunteers": false, "eligibility": { "minimum_age": "18 Years", "maximum_age": "75 Years", "sex": "ALL", "summary": "18 Years to 75 Years" }, "enrollment_count": 99, "start_date": "2023-02-10", "completion_date": "2023-11-09", "has_results": false, "last_update_posted_date": "2023-11-21", "last_synced_at": "2026-10-22T23:53:21.453Z", "location_count": 17, "location_summary": "Gardena, California • Huntington Park, California • Panorama City, California + 13 more", "locations": [ { "city": "Gardena", "state": "California" }, { "city": "Huntington Park", "state": "California" }, { "city": "Panorama City", "state": "California" }, { "city": "Santa Ana", "state": "California" }, { "city": "Lady Lake", "state": "Florida" } ], "official_url": "https://clinicaltrials.gov/study/NCT05591079" }, { "nct_id": "NCT01790113", "title": "Arthrex Eclipse™ Shoulder Prosthesis", "overall_status": "TERMINATED", "study_type": "INTERVENTIONAL", "phases": [ "NA" ], "conditions": [ "Osteoarthritis" ], "interventions": [ { "name": "Univers™", "type": "DEVICE" }, { "name": "Eclipse™ Total Shoulder Replacement", "type": "DEVICE" } ], "intervention_types": [ "DEVICE" ], "sponsor": "Arthrex, Inc.", "sponsor_class": "INDUSTRY", "healthy_volunteers": false, "eligibility": { "minimum_age": "21 Years", "maximum_age": null, "sex": "ALL", "summary": "21 Years and older" }, "enrollment_count": 303, "start_date": "2013-02-04", "completion_date": "2019-06-07", "has_results": true, "last_update_posted_date": "2021-02-03", "last_synced_at": "2026-10-22T23:53:21.453Z", "location_count": 16, "location_summary": "Sun City, Arizona • Redwood City, California • Denver, Colorado + 13 more", "locations": [ { "city": "Sun City", "state": "Arizona" }, { "city": "Redwood City", "state": "California" }, { "city": "Denver", "state": "Colorado" }, { "city": "Chicago", "state": "Illinois" }, { "city": "Louisville", "state": "Kentucky" } ], "official_url": "https://clinicaltrials.gov/study/NCT01790113" }, { "nct_id": "NCT03502824", "title": "PuraPly® AM Plus the Standard of Care to Standard of Care Alone for the Management of Stage II-IV Pressure Ulcers.", "overall_status": "TERMINATED", "study_type": "INTERVENTIONAL", "phases": [ "NA" ], "conditions": [ "Chronic Pressure Ulcers" ], "interventions": [ { "name": "PuraPly® Antimicrobial Wound Matrix", "type": "DEVICE" }, { "name": "SOC for Pressure Ulcers", "type": "OTHER" } ], "intervention_types": [ "DEVICE", "OTHER" ], "sponsor": "Organogenesis", "sponsor_class": "INDUSTRY", "healthy_volunteers": false, "eligibility": { "minimum_age": "18 Years", "maximum_age": "99 Years", "sex": "ALL", "summary": "18 Years to 99 Years" }, "enrollment_count": 40, "start_date": "2018-05-01", "completion_date": "2021-09-15", "has_results": false, "last_update_posted_date": "2021-09-22", "last_synced_at": "2026-10-22T23:53:21.453Z", "location_count": 2, "location_summary": "Lake Success, New York • Mineola, New York", "locations": [ { "city": "Lake Success", "state": "New York" }, { "city": "Mineola", "state": "New York" } ], "official_url": "https://clinicaltrials.gov/study/NCT03502824" }, { "nct_id": "NCT02211547", "title": "Effect of Low Level Laser Therapy on Pain Induced by Placement of Orthodontic Separators in Pediatric Patients", "overall_status": "WITHDRAWN", "study_type": "INTERVENTIONAL", "phases": [ "NA" ], "conditions": [ "Levels of Pain" ], "interventions": [ { "name": "Epic 10 Diode Laser by Biolase Inc.", "type": "DEVICE" }, { "name": "Placebo", "type": "OTHER" } ], "intervention_types": [ "DEVICE", "OTHER" ], "sponsor": "University of Colorado, Denver", "sponsor_class": "OTHER", "healthy_volunteers": true, "eligibility": { "minimum_age": "6 Years", "maximum_age": "17 Years", "sex": "ALL", "summary": "6 Years to 17 Years" }, "enrollment_count": 0, "start_date": "2014-08", "completion_date": "2015-10", "has_results": false, "last_update_posted_date": "2017-01-31", "last_synced_at": "2026-10-22T23:53:21.453Z", "location_count": 1, "location_summary": "Aurora, Colorado", "locations": [ { "city": "Aurora", "state": "Colorado" } ], "official_url": "https://clinicaltrials.gov/study/NCT02211547" }, { "nct_id": "NCT07128615", "title": "A Phase I/II Study on Safety AND Immunogenicity of AZD4117 and AZD5315 Vaccines (PANDA)", "overall_status": "ACTIVE_NOT_RECRUITING", "study_type": "INTERVENTIONAL", "phases": [ "PHASE1", "PHASE2" ], "conditions": [ "Influenza A" ], "interventions": [ { "name": "AZD4117", "type": "BIOLOGICAL" }, { "name": "AZD5315", "type": "BIOLOGICAL" }, { "name": "Placebo", "type": "OTHER" } ], "intervention_types": [ "BIOLOGICAL", "OTHER" ], "sponsor": "AstraZeneca", "sponsor_class": "INDUSTRY", "healthy_volunteers": true, "eligibility": { "minimum_age": "18 Years", "maximum_age": null, "sex": "ALL", "summary": "18 Years and older" }, "enrollment_count": 405, "start_date": "2025-09-04", "completion_date": "2026-12-29", "has_results": false, "last_update_posted_date": "2026-10-09", "last_synced_at": "2026-10-22T23:53:21.453Z", "location_count": 14, "location_summary": "Long Beach, California • Rolling Hills Estates, California • Miami Lakes, Florida + 11 more", "locations": [ { "city": "Long Beach", "state": "California" }, { "city": "Rolling Hills Estates", "state": "California" }, { "city": "Miami Lakes", "state": "Florida" }, { "city": "Stockbridge", "state": "Georgia" }, { "city": "Chicago", "state": "Illinois" } ], "official_url": "https://clinicaltrials.gov/study/NCT07128615" }, { "nct_id": "NCT03151798", "title": "The Liver Health Study for Patients with NAFLD", "overall_status": "COMPLETED", "study_type": "INTERVENTIONAL", "phases": [ "NA" ], "conditions": [ "Nonalcoholic Fatty Liver", "Nonalcoholic Steatohepatitis", "Obesity" ], "interventions": [ { "name": "Phase II: Lifestyle treatment", "type": "BEHAVIORAL" }, { "name": "Phase II: Control treatment", "type": "BEHAVIORAL" }, { "name": "Phase I: Observational studies", "type": "OTHER" } ], "intervention_types": [ "BEHAVIORAL", "OTHER" ], "sponsor": "University of Missouri-Columbia", "sponsor_class": "OTHER", "healthy_volunteers": false, "eligibility": { "minimum_age": "22 Years", "maximum_age": "65 Years", "sex": "ALL", "summary": "22 Years to 65 Years" }, "enrollment_count": 336, "start_date": "2017-08-09", "completion_date": "2023-04-29", "has_results": false, "last_update_posted_date": "2024-12-19", "last_synced_at": "2026-10-22T23:53:21.453Z", "location_count": 1, "location_summary": "Columbia, Missouri", "locations": [ { "city": "Columbia", "state": "Missouri" } ], "official_url": "https://clinicaltrials.gov/study/NCT03151798" }, { "nct_id": "NCT01019187", "title": "Cognitive Behavioral Therapy With or Without Armodafinil in Treating Cancer Survivors With Insomnia and Fatigue After Chemotherapy", "overall_status": "COMPLETED", "study_type": "INTERVENTIONAL", "phases": [ "PHASE2" ], "conditions": [ "Unspecified Adult Solid Tumor, Protocol Specific" ], "interventions": [ { "name": "Quality of Life Assessment", "type": "PROCEDURE" }, { "name": "Questionnaire Administration", "type": "OTHER" }, { "name": "Placebo", "type": "OTHER" }, { "name": "Fatigue assessment and management", "type": "PROCEDURE" }, { "name": "Sleep disorder therapy", "type": "PROCEDURE" }, { "name": "Armodafinil", "type": "DRUG" }, { "name": "Management of Therapy", "type": "PROCEDURE" }, { "name": "Cognitive Assessment", "type": "PROCEDURE" }, { "name": "Management of therapy and complications", "type": "PROCEDURE" }, { "name": "Fatifue assessment and management", "type": "PROCEDURE" } ], "intervention_types": [ "PROCEDURE", "OTHER", "DRUG" ], "sponsor": "Abramson Cancer Center at Penn Medicine", "sponsor_class": "OTHER", "healthy_volunteers": false, "eligibility": { "minimum_age": "21 Years", "maximum_age": "75 Years", "sex": "ALL", "summary": "21 Years to 75 Years" }, "enrollment_count": 226, "start_date": "2009-06", "completion_date": "2015-08", "has_results": false, "last_update_posted_date": "2020-04-09", "last_synced_at": "2026-10-22T23:53:21.453Z", "location_count": 1, "location_summary": "Philadelphia, Pennsylvania", "locations": [ { "city": "Philadelphia", "state": "Pennsylvania" } ], "official_url": "https://clinicaltrials.gov/study/NCT01019187" }, { "nct_id": "NCT02835755", "title": "Mobile Health Intervention in Increasing HPV Vaccine Coverage Among Young Adult Gay and Bisexual Men", "overall_status": "COMPLETED", "study_type": "INTERVENTIONAL", "phases": [ "NA" ], "conditions": [ "Healthy Subject" ], "interventions": [ { "name": "Educational Intervention", "type": "OTHER" }, { "name": "Survey Administration", "type": "OTHER" } ], "intervention_types": [ "OTHER" ], "sponsor": "Ohio State University Comprehensive Cancer Center", "sponsor_class": "OTHER", "healthy_volunteers": true, "eligibility": { "minimum_age": "18 Years", "maximum_age": "25 Years", "sex": "MALE", "summary": "18 Years to 25 Years · Male only" }, "enrollment_count": 150, "start_date": "2016-07-11", "completion_date": "2017-04-16", "has_results": false, "last_update_posted_date": "2017-08-03", "last_synced_at": "2026-10-22T23:53:21.453Z", "location_count": 1, "location_summary": "Columbus, Ohio", "locations": [ { "city": "Columbus", "state": "Ohio" } ], "official_url": "https://clinicaltrials.gov/study/NCT02835755" }, { "nct_id": "NCT05357378", "title": "Safety and Effectiveness of the HIT Reverse HRS", "overall_status": "RECRUITING", "study_type": "INTERVENTIONAL", "phases": [ "NA" ], "conditions": [ "Degenerative Joint Disease", "Osteoarthritis, Hip", "Avascular Necrosis of Hip", "Traumatic Arthropathy-Hip" ], "interventions": [ { "name": "Hip Innovation Technology Reverse Hip Replacement System", "type": "DEVICE" }, { "name": "Already-marketed semi-constrained uncemented hip systems using a metal-on-XLPE or ceramic-on-XLPE bearing combination.", "type": "DEVICE" } ], "intervention_types": [ "DEVICE" ], "sponsor": "Hip Innovation Technology", "sponsor_class": "INDUSTRY", "healthy_volunteers": false, "eligibility": { "minimum_age": "50 Years", "maximum_age": "75 Years", "sex": "ALL", "summary": "50 Years to 75 Years" }, "enrollment_count": 288, "start_date": "2022-07-15", "completion_date": "2038-09-16", "has_results": false, "last_update_posted_date": "2026-09-21", "last_synced_at": "2026-10-22T23:53:21.453Z", "location_count": 6, "location_summary": "Miami, Florida • Tampa, Florida • Baltimore, Maryland + 2 more", "locations": [ { "city": "Miami", "state": "Florida" }, { "city": "Tampa", "state": "Florida" }, { "city": "Tampa", "state": "Florida" }, { "city": "Baltimore", "state": "Maryland" }, { "city": "Somers Point", "state": "New Jersey" } ], "official_url": "https://clinicaltrials.gov/study/NCT05357378" }, { "nct_id": "NCT00402506", "title": "A Safety and Efficacy Study to Confirm the Cardioprotective Effects of MC-1 in Patients Undergoing High-Risk CABG", "overall_status": "COMPLETED", "study_type": "INTERVENTIONAL", "phases": [ "PHASE3" ], "conditions": [ "Coronary Artery Bypass Graft Surgery", "Myocardial Ischemia", "Reperfusion Injury" ], "interventions": [ { "name": "(MC-1) Pyridoxal 5'-phosphate", "type": "DRUG" } ], "intervention_types": [ "DRUG" ], "sponsor": "Medicure", "sponsor_class": "INDUSTRY", "healthy_volunteers": false, "eligibility": { "minimum_age": "18 Years", "maximum_age": null, "sex": "ALL", "summary": "18 Years and older" }, "enrollment_count": 3000, "start_date": "2006-11", "completion_date": "2007-09", "has_results": false, "last_update_posted_date": "2007-11-16", "last_synced_at": "2026-10-22T23:53:21.453Z", "location_count": 1, "location_summary": "Durham, North Carolina", "locations": [ { "city": "Durham", "state": "North Carolina" } ], "official_url": "https://clinicaltrials.gov/study/NCT00402506" } ] }